{"id":"umeclidinium-62-5-g-and-vilanterol-25-g","safety":{"commonSideEffects":[{"rate":null,"effect":"Tremor"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Palpitations"},{"rate":null,"effect":"Dry mouth"},{"rate":null,"effect":"Urinary retention"}]},"_chembl":null,"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=umeclidinium 62.5 µg and vilanterol 25 µg","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:32:32.388429+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:32:37.594281+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=umeclidinium 62.5 µg and vilanterol 25 µg","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:32:37.903269+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1187833/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:32:39.161495+00:00"}},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Umeclidinium prevents acetylcholine from binding to M3 receptors on airway smooth muscle, reducing bronchoconstriction. Vilanterol activates beta-2 adrenergic receptors, increasing intracellular cAMP and promoting smooth muscle relaxation. The combination provides dual bronchodilation through complementary mechanisms, improving airflow and reducing symptoms in COPD patients.","oneSentence":"Umeclidinium is a long-acting anticholinergic that blocks muscarinic M3 receptors in airway smooth muscle, while vilanterol is a long-acting beta-2 agonist that activates beta-2 adrenergic receptors, together producing bronchodilation for maintenance treatment of chronic obstructive pulmonary disease.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:37:25.684Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:32:41.002627+00:00","fieldsConflicting":0,"overallConfidence":0.95},"indications":{"approved":[{"name":"Chronic obstructive pulmonary disease (COPD) maintenance treatment"}]},"trialDetails":[{"nctId":"NCT07133880","phase":"PHASE4","title":"Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators","status":"RECRUITING","sponsor":"University of Tennessee Graduate School of Medicine","startDate":"2023-12-05","conditions":"COPD (Chronic Obstructive Pulmonary Disease)","enrollment":72}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL1187833"},"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Anoro Ellipta"],"phase":"marketed","status":"active","brandName":"umeclidinium 62.5 µg and vilanterol 25 µg","genericName":"umeclidinium 62.5 µg and vilanterol 25 µg","companyName":"University of Tennessee Graduate School of Medicine","companyId":"university-of-tennessee-graduate-school-of-medicine","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Umeclidinium is a long-acting anticholinergic that blocks muscarinic M3 receptors in airway smooth muscle, while vilanterol is a long-acting beta-2 agonist that activates beta-2 adrenergic receptors, together producing bronchodilation for maintenance treatment of chronic obstructive pulmonary disease. Used for Chronic obstructive pulmonary disease (COPD) maintenance treatment.","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:32:41.002627+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}